Old Web
English
Sign In
Acemap
>
authorDetail
>
Hayri E. Balcioglu
Hayri E. Balcioglu
Erasmus University Rotterdam
Cancer research
Receptor
Immune system
CD28
Cytotoxic T cell
3
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Anti-PD1 efficacy in metastatic urothelial cancer patients associates with intra-tumoral juxtaposition of T helper-type 1 and CD8+ T-cells.
2021
Clinical Cancer Research
Maud Rijnders
Hayri E. Balcioglu
Debbie Robbrecht
Astrid A. M. Oostvogels
Rebecca Wijers
Maureen J.B. Aarts
Paul Hamberg
Geert J.L.H. van Leenders
J. Alberto Nakauma-González
Jens Voortman
Hans M. Westgeest
Joost L. Boormans
Ronald de Wit
Martijn P. Lolkema
Astrid A.M. van der Veldt
Reno Debets
Show All
Source
Cite
Save
Citations (0)
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer.
2021
Nature Communications
Dora Hammerl
John W. M. Martens
Mieke Timmermans
Marcel Smid
Anita M. A. C. Trapman-Jansen
Renée Foekens
Olga I. Isaeva
Leonie Voorwerk
Hayri E. Balcioglu
Rebecca Wijers
Iris Nederlof
Roberto Salgado
Hugo M. Horlings
Marleen Kok
Reno Debets
Show All
Source
Cite
Save
Citations (1)
CD45RA+CCR7− CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab
2019
Journal for ImmunoTherapy of Cancer
Andre Kunert
Edwin A. Basak
Daan P. Hurkmans
Hayri E. Balcioglu
Yarne Klaver
Mandy van Brakel
Astrid A. M. Oostvogels
Cor H. J. Lamers
Sander Bins
Stijn L.W. Koolen
Astrid A.M. van der Veldt
Stefan Sleijfer
Ron H.J. Mathijssen
Joachim Aerts
Reno Debets
Show All
Source
Cite
Save
Citations (19)
1